We are pleased to announce our partnership with both CRF and IQVIA Inc., two world leading research organizations for our plan to conduct DurAVR™ THV FDA early feasibility study! READ FULL ASX ANNOUNCEMENT HERE: https://bit.ly/3l9DcwJ $AVR #TAVR

This year again the Anteris Team will be participating in the @heartfoundation #MyMarathon challenge starting October 1st to help Aussie hearts! We are proud to support heart disease research that can create life-changing outcomes for patients.

Excited to see DurAVR™ THV loaded on a Transfemoral Delivery System and being deployed by our new CMO Dr @chrismeduri .Completion of these pre-clinical studies are a crucial step as we prepare for the start of our in-human studies! #TAVR #lastslongerworksbetter $AVR